REPRESENTATIVE EXPERIENCE Bill’s broad representative experience includes the following:
- Helping a biotherapies research company protect its laboratory techniques and cell culture media for the generation of human pluripotent embryonic stem cells.
- Creating a robust patent portfolio and licensing program for a company with a unique vaccination technology platform.
- Conducting comprehensive due diligence of a molecular bioarray diagnostic patent and licensing portfolio for acquisition.
- Prosecuting patents for a multi-national agriculture company that develops genetically engineered plants resistant to disease, salt, freezing and drought.
- Assisting a cardiovascular medical device company protect implantable prosthetic heart valves and delivery means.
- Providing intellectual property counsel to a company licensing patents for a variety of disease-associated biomarkers and cellular receptors.
- Performing freedom-to-operate analyses for commercialization of therapeutic recombinant proteins and monoclonal antibodies.
- Counseling a diagnostic laboratory on the patentability of novel genetic comparative analyses to detect disease states and vaccination efficacy.
- Assisting numerous universities in patenting a broad array of research tools to enable further discoveries.
PROFESSIONAL HONORS AND AWARDS
- Named among “Georgia’s Legal Elite” by Georgia Trend magazine (2007)
- Selected for inclusion in Georgia Super Lawyers® “Rising Stars” (2006)
PROFESSIONAL AND COMMUNITY INVOLVEMENT
- Member, American Bar Association
- Member, Atlanta Bar Association
- Member, State Bar of Georgia, Intellectual Property Law Section
- Member, Georgia Biotechnology Industry Organization (GaBio)
- Member, American Intellectual Property Law Association
- Member, Intellectual Property Owners Association
- Member, Licensing Executives Society
- Member, Life Sciences Committee, Bioscience Leadership Council, Metro Atlanta Chamber of Commerce
- Member, Association for University Technology Managers
- Member, Board of Councilors, Carter Center
- Trustee, Chi Psi Fraternity Educational Trust
- Founding Member, Corporate Leadership Council of the Fernbank Museum of Natural History
RECENT PUBLICATIONS AND SPEAKING ENGAGEMENTS
- Co-author, “Personalized Medicine Diagnostic Patents,” Genetic Engineering and Biotechnology News (November 2011)
- Co-author, “Difficulty in Patenting Improved Antibodies: Courts Increasingly Invalidating Claims for Lacking Written Description,” Genetic Engineering & Biotechnology News (May 1, 2011)
- Co-author, “Biotechnology Patent Validity in Jeopardy: Recent Decisions on Qualifying Subject Matter Weaken Enforceability of Method Claims,” Genetic Engineering and Biotechnology News (October 1, 2010)
- Author, “Patent Law Reform in the Works Again," Genetic Engineering & Biotechnology News (May 1, 2010)
- Co-author, “DNA - Not Patentable Subject Matter...” Intellectual Property Law360 (March 31, 2010)
- Author, “Gene Patent Ruling Could Shake Up Biotech,” Intellectual Property Law360 (March 30, 2010)
- Co-author, “Certainty Not Required for Inventorship,” Genetic Engineering & Biotechnology News (November 2009)
- Co-author, “Upcoming Changes to European Patent Examination Procedures,” Patent Strategy & Management (August 2009)
- Co-author, “Special Report: Patentability of Genetic Sequences Limited,” Genetic Engineering & Biotechnology News (May 13, 2009)
- Co-author, “The Third Amendment to the Chinese Patent Law,” Patent Strategy & Management (May 1, 2009)
- Co-author, “Is Safe Harbor Closed to Research Tools?” Genetic Engineering and Biotechnology News, Volume 28, Number 19 (November 1, 2008)
- Co-author, “Redefining Written Descriptions for Patents,” Genetic Engineering and Biotechnology News, Vol. 28, No. 18 (October 15, 2008)
- Co-author, “Abbreviated Approval of Generic Biologics,” Genetic Engineering News (December 2006)
- Co-author, “Analysis of a Patent Applicant’s Obligations,” Genetic Engineering News (May 2006)
- Author, “Safe Harbor Provisions for Preclinical Research,” Genetic Engineering News (August 2005)
- Author, “Currently Evolving Regulatory and Patent Issues Affecting Biotechnology,” Genetic Engineering News (June 2005)
- Reference, “The Evolution of Patent Infringement,” Corporate Legal Times (April 2005)
- Co-author, “The Create Act of 2004,” Intellectual Asset Management (December 10, 2004)
- Co-author, “Description Requirements for Patenting Genes,” Genetic Engineering News, Volume 24, Number 19 (November 1, 2004)
- Speaker, Southeastern Medical Device Association (SEMDA) Annual Conference, (March 13-14, 2012)
- Speaker, “Overview of U.S. and International Patent Process,” Urologic Invention Convention (May 14, 2010)
- Speaker, “Industry is from Mars and Academia is from Venus: Establishing Successful Collaborative Research Programs,” BIO International Conference, Atlanta, Georgia (May 2009)
- Speaker, Start-Up Boot Camp, Cornell University (November 2008)
- Speaker, Biotech Entrepreneurship, University of Georgia (January 2007)
- Speaker, Provisional Patent Strategies, Association of University Technology Managers (AUTM) Regional Conference (November 2006)
- Speaker, Corporate Intellectual Property in China 2006 (April 20-21, 2006)
- Speaker, “Provisional Patents: To File Or Not To File,” AUTM Graduate Course (December 1-3, 2005)
- Panelist, Second Annual Southeast Workshop on Tissue Engineering and Biomaterials (February 11-12, 2005)
- Speaker, Georgia Biomedical Partnership's Annual Award Dinner and 15th Anniversary Celebration (January 19, 2005)
- Speaker, The Genomic Revolution (June 12, 2004 - January 2, 2005)
- Speaker, “Recent Patent Law Developments in Experimental Use Exceptions,” The Association for Research in Vision and Ophthalmology Annual Meeting (May 2-9, 2003)